Patent Assignment
Reel/Frame 073111/0142
Release of Security Interest in Patents at Reel/Frame No. 67396/0532
Recorded: 2025-10-14
Pages: 16
Assignor
WILMINGTON SAVINGS FUND SOCIETY, FSB, AS AGENT
Executed: 2025-10-14
Assignee
KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE, NEWTON, MASSACHUSETTS, 02459
Covered Properties
(48)
Uses of Il-12 in Hematopoiesis
Method for Treating Deficiency in Hematopoiesis
Nuclear Transport Modulators and Uses Thereof
Uses of Il-12 in Hematopoiesis
Uses of Il-12 in Hematopoiesis
Method for Treating Brain Cancer Using a Novel Tumor Suppressor Gene and Secreted Factor
Il-12 Formulations for Enhancing Hematopoiesis
Methods for Radiation Protection by Administering Il-12
Uses of Il-12 and the Il-12 Receptor Positive Cell in Tissue Repair and Regeneration
Nuclear Transport Modulators and Uses Thereof
Mitigation of Cutaneous Injury with Il-12
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Il-12 for Radiation Protection and Radiation-Induced Toxicity Mitigation
Uses of Il-12 in Hematopoiesis
Substituted 2,3-Dihydrobenzofuranyl Compounds And Uses Thereof
Hydrazide Containing Nuclear Transport Modulators And Uses Thereof
Methods of Promoting Wound Healing Using CRM1 Inhibitors
Nuclear Transport Modulators and Uses Thereof
Substituted Benzofuranyl and Benzoxazolyl Compounds and Uses Thereof
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Multicyclic Compounds And Methods Of Using Same
Polymorphs of Selinexor
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
(S,E)-3-(6-Aminopyridin-3-Yl)-N-((5-(4-(3-Fluoro-3-Methylpyrrolidine-1-Carbonyl)Phenyl)-7-(4-Fluorophenyl)Benzofuran-2-Yl)Methyl)Acrylamide for the Treatment of Cancer
Highly Active, Robust and Versatile Multifunctional, Fully Non-Noble Metals Based Electro-Catalyst Compositions and Methods of Making for Energy Conversion and Storage
Substituted Benzofuranyl and Benzoxazolyl Compounds and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Multicyclic Compounds and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Substituted Benzofuranyl and Benzoxazolyl Compounds and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Polymorphs of Selinexor
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Substituted Benzofuranyl and Benzoxazolyl Compounds and Uses Thereof
The Combination of XPO1 Inhibitors and Second Agents for the Treatment of Prostate Cancer
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Polymorphs of Selinexor
Il-12 Compositions and Methods of Use in Hematopoietic Recovery
Application:
17/368,346 →
Publication:
US 2022/0168393
Nuclear Transport Modulators and Uses Thereof
Biomarkers for Selinexor
Application:
17/598,101 →
Publication:
US 2022/0178927
Process for Preparing XPO1 Inhibitors and Intermediates for Use in the Preparation of XPO1 Inhibitors
Crystalline Form of Selinexor
Application:
18/032,949 →
Publication:
US 2023/0391754
Polymorphs of Selinexor
Polymorphs of Selinexor
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 22, 2018
From: BALOGLU, ERKAN; SHECHTER, SHARON; SHACHAM, SHARON; MCCAULEY, DILARA
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 045415/0779 →
Security Interest
Aug 8, 2019
From: NEUMEDICINES INC.
To: NITTO AVECIA PHARMA SERVICES, INC.
Reel/Frame 050004/0751 →
Notice of Security Interest in Patents
Sep 27, 2019
From: KARYOPHARM THERAPEUTICS INC.
To: HCR COLLATERAL MANAGEMENT, LLC
Reel/Frame 050575/0574 →
Security Interest
Jun 16, 2020
From: NEUMEDICINES INC.
To: FRIEDMAN, ELLIOT
Reel/Frame 052956/0270 →
Notice of Termination and Release of Patent Liens and Security Interests
Jul 28, 2021
From: NEUMEDICINES INC.
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 057012/0881 →
Assignment of Assignor's Interest
Dec 15, 2023
From: NEUMEDICINES INC.
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 065879/0436 →
Security Interest
May 8, 2024
From: KARYOPHARM THERAPEUTICS INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 067345/0255 →
Second Lien Patent Security Agreement
May 13, 2024
From: KARYOPHARM THERAPEUTICS INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 067396/0532 →
Patent Security Agreement
Oct 10, 2025
From: KARYOPHARM THERAPEUTICS INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL TRUSTEE
Reel/Frame 073058/0504 →